Comprehensive, precise diabetes and blood disorders monitoring
Bio-Rad offers a variety of quality controls intended to monitor the precision of test procedures for analytes used in diagnosing and monitoring the treatment of diabetes and other blood disorders. These include a comprehensive line of glucose and hemoglobin controls as well as HbA1c linearity controls suitable for low- to high-volume labs. Available for most major platforms and in a variety of configurations, our controls add convenience and help improve the precision of your testing. Together with our leading Unity software, Bio-Rad’s diabetes and hemoglobin controls help maintain confidence in the reliability of your test results.
We offer a human whole blood-based control designed to verify linearity throughout the assay reportable range of HbA1c test methods. The A1c test results shows average levels of blood glucose over a period of time, and it is used to monitor type 1 and 2 diabetes and prediabetes.
We offer a variety of hemoglobin controls, including controls to monitor tests for hemoglobins A2 (linked to beta thalassemia, an inherited blood disorder), F, and S. Our lyophilized control is designed to monitor the precision of automated and manual procedures.
With a large number of value assignments, our controls are suitable for use on various instruments worldwide, including Roche, Siemens, Tosoh, and others. They can be used from core labs to commercial research labs.
Comprehensive diabetes and linearity analytes enhance testing capability
Variety of configurations add convenience
Available for most major manufacturers’ analyzers
Monitor precision at clinically relevant ranges.
Long shelf lives reduce labor and save money
Unity software offers large peer group for improved test performance
Some benefits for registering